Ellen H Fiss

Title: **Ellen H Fiss: Innovator in Microbial Detection Technologies**

Introduction

Ellen H Fiss, based in Albany, CA, is a prolific inventor with an impressive portfolio of 22 patents. Her innovations primarily focus on microbial detection and inactivation methods, contributing significantly to the field of molecular biology and diagnostics.

Latest Patents

Among her latest contributions, Fiss holds a patent for a "Method of inactivating microbes by citraconic anhydride." This invention outlines techniques for preparing inactivated microbes, which are essential for formulating internal control reagents in recombinant nucleic acid techniques, particularly useful in nucleic acid amplification methods such as the polymerase chain reaction (PCR). Another notable patent describes "Methods for the rapid detection of the presence or absence in a biological or non-biological sample." This includes performing amplification, hybridization, and detection steps, alongside primers and probes designed for effective detection.

Career Highlights

Throughout her career, Ellen H Fiss has made significant strides in the field of biotechnology. She has worked with esteemed organizations, such as Roche Molecular Systems, Inc. and Bayer Corporation, where her expertise contributed to advancements in microbial detection and infection control technologies.

Collaborations

Fiss has collaborated with distinguished professionals, including Thomas W Myers and Jingtao Sun. These collaborations have likely fostered innovation and enhanced the development of new technologies within her research area.

Conclusion

Ellen H Fiss is a remarkable inventor whose work in microbial detection and inactivation has paved the way for advancements in molecular diagnostics. Her numerous patents are a testament to her innovative spirit and commitment to improving healthcare technologies. As the field continues to evolve, her contributions will undoubtedly play a critical role in shaping future methodologies and applications.